학술논문

668PUpdated analysis of a phase II study of SOX plus trastuzumab for the patients with HER2 positive advanced or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS1501B.
Document Type
Article
Source
Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
Subject
*STOMACH cancer
*TRASTUZUMAB
*SOCKS
Language
ISSN
0923-7534